Lynkuet Shows Promise for Relieving Menopause Symptoms

Hot flashes and night sweats aren’t just uncomfortable they can be deeply disruptive to a woman’s life. Affecting up to 80% of women during menopause, these symptoms can last seven to ten years, leading to poor sleep, mood changes, and daily discomfort. While hormone therapy has long been the primary treatment, a new nonhormonal medication is creating fresh options for those seeking relief.

What Is Lynkuet and How Does It Work?

Lynkuet (elinzanetant), recently approved by the FDA, is the latest entrant in a new class of nonhormonal treatments for menopause symptoms. Unlike hormone replacement therapy (HRT), which adds estrogen and/or progesterone to a woman’s system, Lynkuet works by blocking two specific brain receptors neurokinin 1 (NK1) and neurokinin 3 (NK3). These receptors play a key role in regulating the body’s internal thermostat.

By targeting both NK1 and NK3, Lynkuet goes a step further than its predecessor, Veozah, which only blocks NK3. According to clinical trials, this dual-action approach helped over 70% of women reduce their hot flashes by at least 50% within 12 weeks. Improvements often began within just one week of use.

Who Might Benefit Most From Lynkuet?

Hormone replacement therapy has been a standard treatment since the 1940s, but it’s not for everyone. Concerns around blood clots, breast cancer, and stroke, particularly after a 2002 Women’s Health Initiative study, have made some women cautious despite more recent research confirming that HRT is generally safe when started around menopause.

Lynkuet is ideal for women who:

• Can’t take hormone therapy due to personal or family medical history

• Prefer nonhormonal options

• Have tried other treatments like Gabapentin or Effexor with limited success

Doctors recommend discussing the following questions before starting Lynkuet:

• Is this medication suitable for my symptoms and health history?

• When can I expect to feel improvement?

• Could this also help with sleep quality?

• Are there any other nonhormonal options worth trying?

What About Side Effects?

As with any medication, Lynkuet comes with a list of potential side effects. The most commonly reported include:

• Headache

• Fatigue or drowsiness

• Dizziness

• Abdominal discomfort

• Rash or diarrhea

• Muscle spasms

Women are also advised to avoid grapefruit and grapefruit juice, which can interfere with how the medication is metabolized.

Additionally, the FDA has mandated liver function tests before starting Lynkuet and again after three months. This precaution follows rare instances of liver issues in users of Veozah, a similar drug. If test results are normal, no further monitoring is typically needed.

Cost and Access to Lynkuet

With a list price of $650 per month, cost may be a barrier for some. Bayer has indicated it will offer a savings program to improve access. However, insurers may first require patients to try other lower-cost medications before approving Lynkuet.

A New Chapter in Menopause Care

With more women speaking up about their menopause experiences and demanding better treatment options, the approval of Lynkuet marks an important step forward. It offers a well-tolerated, effective, and nonhormonal alternative for those navigating the often difficult symptoms of menopause.

Menopause should not be a silent struggle. And with science continuing to evolve, women now have more choices than ever to take control of their well-being.

If this article was helpful, subscribe to our newsletter or share it with someone navigating menopause.